- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04852055
Effect of an Advance Care Planning Intervention
October 13, 2025 updated by: Vincent Mor, Brown University
Effect of an Advance Care Planning Intervention on Documentation of Advance Directives and Goals of Care in Assisted Living Centers
The intervention being studied is an advance care planning intervention.
The trial has two arms: usual care and information arm.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Eligible patients whose assisted living centers are randomized to the information arm will receive a letter from their clinician with links to informational video.
Eligible patients whose assisted living centers are randomized to the usual care arm have advance care planning discussions with a clinician at admission, annually, and sometimes with a hospitalization or other change in condition.
Study Type
Interventional
Enrollment (Actual)
2364
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Stillwater, Minnesota, United States, 55082-6788
- Bluestone Physician Services
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Partnering assisted living center with at least 20 patients with a dementia diagnosis (based on International Classification of Diseases, version 10 codes)
- Patients not on hospice
- Patients who do not have comfort care or do-not-hospitalize orders at baseline
Exclusion Criteria:
- Partnering assisted living center with less than 20 patients with a dementia diagnosis (based on International Classification of Diseases, version 10 codes)
- Patients on hospice
- Patients with comfort care or do-not-hospitalize orders at baseline
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual Care
Patients and proxies in assisted living centers randomized to the usual care arm have advance care planning discussions with a clinician at admission, annually, and sometimes with a hospitalization or other change in condition.
There is no standardized decision- or conversation-support tools used to have these discussions.
|
|
|
Experimental: Information
Patients and proxies in assisted living centers randomized to the information arm will receive a letter from their clinician with a link to an educational video describing the goals of care and how specific treatment decisions align with these goals.
Patients and proxies will also continue to receive usual care advance care planning conversations.
|
Clinical assistants determine who is the correct person to receive the informational materials.
If the patient is the correct recipient, clinicians will send the informational materials to the patient at the assisted living center.
If the proxy is the correct recipient, the clinical assistant will determine whether or not the proxy is using the existing online portal.
If the proxy is using the portal, the informational materials will be sent electronically.
If the proxy does not access the portal, the informational materials will be sent to their residences.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Do-Not-Resuscitate
Time Frame: 4 months
|
Percentage of residents with do-not-resuscitate orders documented in the electronic health record at end of follow-up, comparison between usual care and experimental arm
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Do-Not-Hospitalize
Time Frame: 4 months
|
Percentage of residents in each arm with do-not-hospitalize or comfort care orders documented in the electronic health record at end of follow-up, comparison between usual care and experimental arm
|
4 months
|
|
Advance Care Planning Billing
Time Frame: 4 months
|
Percentage of residents in each arm with current procedural terminology billing code for advance care planning during follow-up based on Medicare claims data, comparison between usual care and experimental arm.
|
4 months
|
|
Hospitalization
Time Frame: 4 months
|
Percentage of residents with any inpatient hospitalization during follow-up based on Medicare claims data (the MedPAR file), comparison between usual care and experimental arm.
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Vincent Mor, PhD, Brown University, School of Public Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2021
Primary Completion (Actual)
March 23, 2022
Study Completion (Actual)
March 23, 2022
Study Registration Dates
First Submitted
April 16, 2021
First Submitted That Met QC Criteria
April 16, 2021
First Posted (Actual)
April 21, 2021
Study Record Updates
Last Update Posted (Estimated)
November 4, 2025
Last Update Submitted That Met QC Criteria
October 13, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008002779
- 3U54AG063546-02S1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.